Showing results (91-100 of 275) with videos related to
Sort By:
Pageof 28
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1996
Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2S Salvadori, K ZierArzneimittel-Forschung|August 1, 1994
Synthesis and biological activity of D-glucopyranosyl peptide T derivativesM Marastoni, S Spisani, R TomatisFarmaco (Societa Chimica Italiana : 1989)|December 1, 1989
Synthesis and biological activity of a cyclic hexapeptide related to peptide TS Bianchi, V Scaranari, R TomatisArzneimittel-Forschung|November 24, 1998
Synthesis and biological activity of chelator-peptide T conjugatesM Marastoni, S Spisani, R TomatisCancer Immunology, Immunotherapy : CII|September 9, 1999
Generation of anti-allogeneic cytotoxic T lymphocytes depends upon a signal, not delivered by tumor cells, that can be provided in trans in the presence of exogenous interleukin-2K S Zier, S SalvadoriJournal of Medicinal Chemistry|August 24, 2000
Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptorR Guerrini, G Caló, R Bigoni, et al.International Journal of Peptide and Protein Research|January 1, 1976
Studies on trypsin inhbitors. Part II. Synthesis of the protected tetrapeptide (sequence 11-14) of porcine pancreatic secretory trypsin inhibitor II (Kazal)A Guggi, R Tomatis, V Periotto, et al.International Journal of Peptide and Protein Research|January 1, 1976
Studies on trypsin inhibitors. Part V. Synthesis of the protected octapeptide (sequence 36-43) of porcine pancreatic secretory trypsin inhibitor II (Kazal)R Tomatis, A Guggi, E Menegatti, et al.International Journal of Peptide and Protein Research|January 1, 1976
Studies on trypsin inhibitors. Part III. Synthesis of the protected decapeptide (sequence 15-24) of porcine pancreatic secretory trypsin inhibitor II (Kazal)R Tomatis, A Guggi, R Ferroni, et al.Arzneimittel-Forschung|July 1, 1997
Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structureM Marastoni, M Bergonzoni, F Bortolotti, et al.Pageof 28